MPM Oncology Impact Management LP, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 97,920 shares at $32.07 ($2.5M) on 2021-04-07, disclosed to the SEC on 2021-04-09.
Open-market sale of $2.5M ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 15,670 | $0 | 0.0% |
| 2 | $32.07 | 5,295 | $170K | 6.7% |
| 3 | $32.07 | 5,295 | $170K | 6.7% |
| 4 | $32.84 | 3,083 | $101K | 4.0% |
| 5 | $32.84 | 3,083 | $101K | 4.0% |
| 6 | $33.84 | 1,300 |
| $44K |
| 1.7% |
| 7 | $30.51 | 31,890 | $973K | 38.2% |
| 8 | $30.51 | 31,890 | $973K | 38.2% |
| 9 | $31.01 | 414 | $13K | 0.5% |
| Total | $25.99 avg | 97,920 | $2.5M | 100% |
| Filing → |
| HARP | SELL | 2021-04-15 | $1.5M | — | Filing → |
| ITOS | SELL | 2021-04-13 | $6K | — | Filing → |
| CGEM | BUY | 2021-01-14 | $6.3M | — | Filing → |